Related Experiment Videos

[The anticoagulation clinic: that can not be ignored]

H Boccalon1

  • 1Service de médecine vasculaire, CHU de Rangueil-Larrey, 1, avenue Jean-Poulhès-TSA 50032, 31059 Toulouse 09, France. boccalon.h@chu-toulouse.fr

Annales De Cardiologie Et D'Angeiologie
|February 7, 2006
PubMed

Insights

Vitamin K antagonist (VKA) treatment complications persist despite recommendations. Anticoagulation clinics (AC) effectively reduce bleeding and clotting events through patient education and dosage management.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Patient Safety

Context:

  • 1% of the French population uses vitamin K antagonists (VKA).
  • Drug absorption complications are frequent with VKA therapy.
  • Existing recommendations have not reduced VKA-related complications.

Purpose:

  • To evaluate the clinical efficiency and cost-effectiveness of Anticoagulation Clinics (AC) versus conventional follow-up for VKA therapy.
  • To assess the impact of structured patient education and dosage management within AC.
  • To advocate for enhanced rigorous therapeutic steps in managing antithrombotics.

Summary:

  • Anticoagulation Clinics (AC), incorporating patient education and precise dosage calculation, have demonstrated success in reducing hemorrhagic and thrombotic events in other countries.
  • A multicenter prospective evaluation in France compares AC with conventional follow-up for VKA patients.
  • The study highlights the need for improved support for all antithrombotics due to their complexity.

Impact:

  • AC can significantly reduce major bleeding and thrombotic recurrences in patients on VKA therapy.
  • Implementing AC models may improve patient safety and therapeutic outcomes for antithrombotic treatments.
  • Standardizing rigorous therapeutic management, including patient education, is crucial for complex medications like antithrombotics.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...